LMAT LeMaitre Vascular
LeMaitre Vascular earnings company data as of 4:46 AM ET 10/14
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 0.69 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by LMAT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $8M sold by 5 insiders outside a trading plan
- $22M sold by 1 insider under 10b5-1 plans
-
George W LeMaitre CEOSale$5M 46,481 shares at $108.27 3.1% of stakeTraded May 7–8 Filed May 11
-
Trent G Kamke Senior V. P., OperationsSale$313K 2,928 shares at $107.00 44% of stakeTraded May 8 Filed May 11
-
Bridget A Ross DirectorSale$560K 5,044 shares at $111.10 56% of stakeTraded May 7 Filed May 11
-
Lawrence J Jasinski DirectorSale$434K 3,943 shares at $110.00 46% of stakeTraded May 7 Filed May 11
-
Trent G Kamke Senior V. P., OperationsSale$285K 2,625 shares at $108.50 28% of stakeTraded Mar 11 Filed Mar 13
-
David B Roberts President and DirectorSale$357K 3,312 shares at $107.68 18% of stakeTraded Mar 11 Filed Mar 13
-
Trent G Kamke Senior V. P., OperationsSale$115K 1,044 shares at $110.29 14% of stakeTraded Feb 27 Filed Mar 2
-
David B Roberts President and DirectorSale$904K 8,464 shares at $106.80 32% of stakeTraded Feb 27 Filed Mar 2
-
George W LeMaitre CEOPlanned sale$22M 205,930 shares at $107.04 12% of stakeTraded Feb 26–Mar 2 Filed Mar 2
Also filed in the last 12 months, not counted as buying or selling: 81 option exercises, 27 share withholdings for taxes, 22 stock grants, and 4 gifts.
SEC filings
Recent issuer filings from EDGAR, 11 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.